Michael Matson
Stock Analyst at Needham
(2.28)
# 2,654
Out of 5,182 analysts
23
Total ratings
64.29%
Success rate
5.31%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $136.65 | +209.55% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $6.99 | +1,187.55% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $68.61 | -22.75% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $94.38 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $219.51 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $65.69 | - | 1 | Dec 8, 2017 | |
| KTWO K2 Capital Acquisition | Downgrades: Buy | n/a | $9.94 | - | 2 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $65.21 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $329.65 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $8.70 | - | 1 | Mar 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $79.44 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.24 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.42 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $932.43 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $136.65
Upside: +209.55%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $6.99
Upside: +1,187.55%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $68.61
Upside: -22.75%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $94.38
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $219.51
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $65.69
Upside: -
K2 Capital Acquisition
Dec 8, 2017
Downgrades: Buy
Price Target: n/a
Current: $9.94
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $65.21
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $329.65
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $8.70
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $79.44
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.24
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $5.42
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $932.43
Upside: -